Proteintech Group, the benchmark in antibodies, today announces an agreement to purchase HumanZyme. HumanZyme is a leading manufacturer of recombinant human proteins. Their proprietary human cell-expression system generates authentic human proteins that have greater biological activity and stability than competitors’ systems. With this acquisition, Proteintech Group further solidifies its position as a leading manufacturer of antibodies, proteins and ELISA kits.
You Might Also Like
Parse Biosciences Announces Partnership With Research Instruments Group to Offer RNA-Seq Kits in Singapore and Southeast Asia Region
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
